|Systematic (IUPAC) name|
|Molecular mass||374.45 g/mol|
5F-NNE1 (also known as 5F-NNEI and 5F-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-NNE1 may release 1-naphthylamine, a known carcinogen.
Sweden's public health agency suggested classifying 5F-NNE1 as hazardous substance on November 10, 2014.
- "5F-NNEI". Southern Association of Forensic Scientists. Retrieved 24 July 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
- Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
- "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
|This cannabinoid related article is a stub. You can help Infogalactic by expanding it.|